We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lab21 Acquires Business and Assets of Delphic Diagnostics

By LabMedica International staff writers
Posted on 04 Dec 2009
Lab21, (Cambridge, UK) the healthcare diagnostics company, has acquired business and assets of Delphic Diagnostics (London, UK), a specialist laboratory services business with expertise in human immunodeficiency virus (HIV) and hepatitis. More...
The financial details of the acquisition have not been disclosed.

Delphic's business is focused on personalized medicine and companion diagnostics. It has developed a world leading expertise in pharmacology, virology, therapeutic drug monitoring, and specialist clinical trial services to the pharmaceutical industry. It has laboratories in Liverpool and in Kent and partner laboratories across Europe. It has strong quality accreditations, with more than 200 National Health Service (NHS; UK) customers and partnerships with various global pharmaceutical manufacturers.

Graham Mullis, CEO of Lab21, commented, "This acquisition is highly complementary to Lab21's existing business in companion diagnostics, and significantly extends our laboratory capacity and service offering in virology." Mr. Mullis added, "This acquisition is the latest step in our buy-and-build strategy and reinforces our market leadership position in molecular diagnostic services in the UK, specifically in the rapidly growing market for companion diagnostics."

Lab21 supplies tests and services across a broad range including pharmacogenetic tests, gold-standard viral diagnostics, cytochrome P450 genotyping, and viral resistance mapping

Related Links:
Lab21
Delphic Diagnostics


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.